Stockscreener 앱 받기
4.63
8.86%
-0.45
시간 외 거래:
4.63
전일 마감가:
$5.08
열려 있는:
$5.01
하루 거래량:
431.94K
Relative Volume:
2.35
시가총액:
$33.26M
수익:
-
순이익/손실:
$-21.21M
주가수익비율:
-0.142
EPS:
-32.6
순현금흐름:
$-16.86M
1주 성능:
+5.71%
1개월 성능:
+18.41%
6개월 성능:
+2.21%
1년 성능:
+7.42%
1일 변동 폭
$4.60
$5.13
1주일 범위
$4.30
$5.448
52주 변동 폭
$3.20
$6.01
Cingulate Inc Stock (CING) Company Profile
명칭
Cingulate Inc
전화
(913) 942-2300
주소
1901 W. 47TH PLACE, KANSAS CITY
CING을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CING
Cingulate Inc
|
4.63 | 36.49M | 0 | -21.21M | -16.86M | -32.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cingulate Inc Stock (CING) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 개시 | ROTH MKM | Buy |
| 2023-12-22 | 다운그레이드 | Laidlaw | Buy → Hold |
Cingulate Inc 주식(CING)의 최신 뉴스
Will Cingulate Inc. stock maintain dividend yieldColor and Style Update & trail grip notes for mixed terrain - ulpravda.ru
Is Cingulate Inc. stock attractive after correctionRate Cut & Daily Profit Focused Stock Screening - ulpravda.ru
Why Cingulate Inc. stock remains a top recommendation2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - ulpravda.ru
What analyst consensus says on Cingulate Inc. stockTake Profit & Safe Entry Zone Tips - ulpravda.ru
Profit Recap: Is Cingulate Inc. Equity Warrant stock affected by interest rate hikesJuly 2025 Opening Moves & Fast Momentum Stock Entry Tips - ulpravda.ru
Is Cingulate Inc. stock oversold or undervaluedQuarterly Trade Review & Low Drawdown Investment Ideas - ulpravda.ru
How rising interest rates impact Cingulate Inc. Equity Warrant stockJuly 2025 Summary & Verified Technical Trade Signals - ulpravda.ru
Is Cingulate Inc. Equity Warrant stock affected by interest rate hikesWeekly Gains Report & Reliable Price Breakout Signals - ulpravda.ru
Is Cingulate Inc. Equity Warrant stock trading at a premium valuation2025 Big Picture & Community Supported Trade Ideas - ulpravda.ru
Will Cingulate Inc. Equity Warrant stock gain from lower inflationMarket Risk Summary & High Accuracy Investment Signals - ulpravda.ru
How geopolitical tensions affect Cingulate Inc. stockQuarterly Market Review & Long-Term Capital Growth Strategies - ulpravda.ru
Will Cingulate Inc. stock continue dividend increasesStock Rotation Strategies & Free High Yield Growth Strategies - ulpravda.ru
Crypto: Cingulate, Inc.: The Secret Behind a Stunning 79.64% Surge – Hidden Patterns Revealed - InteractiveCrypto
Cingulate CEO cleared of charges, retains board confidence - MSN
Can Cingulate Inc stock weather global recessionQuarterly Profit Review & Growth Focused Entry Point Reports - moha.gov.vn
Cingulate continues stock-for-debt exchanges to reduce liabilities - TipRanks
Cingulate Inc Equity Warrant Stock Analysis and ForecastMarket Rumors and News & Low Risk Investment Tips - earlytimes.in
Trend Review: Is Cingulate Inc Equity Warrant stock affected by interest rate hikes2025 Big Picture & Low Drawdown Trading Techniques - moha.gov.vn
What technical charts say about Cingulate Inc. Equity Warrant stockMACD Histogram Signals & Minimize Portfolio Damage with Warnings - bollywoodhelpline.com
Cingulate Inc. (NASDAQ:CING) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Why Cingulate Inc stock remains a top recommendation2025 Market Trends & Step-by-Step Trade Execution Guides - moha.gov.vn
Will Cingulate Inc. stock return to pre crisis levelsMarket Insider Reports & Swing Trade Smarter With Data Insights - bollywoodhelpline.com
Jobs Data: How analysts rate Cingulate Inc. Equity Warrant stock today2025 Investor Takeaways & Reliable Price Breakout Signals - Улправда
How currency fluctuations impact Cingulate Inc. Equity Warrant stock2025 Earnings Surprises & Weekly Top Gainers Trade List - Улправда
Can Cingulate Inc. stock continue upward trendTrade Risk Assessment & Risk Adjusted Buy and Sell Alerts - Улправда
How analysts rate Cingulate Inc. Equity Warrant stock today2025 Market Overview & Long-Term Investment Growth Plans - Улправда
Bank Watch: Can Cingulate Inc. Equity Warrant stock hit record highs againJuly 2025 Fed Impact & Weekly Market Pulse Alerts - Улправда
Can Cingulate Inc. Equity Warrant stock hit record highs againJuly 2025 EndofMonth & Momentum Based Trading Ideas - Улправда
Cingulate (CING) Stock Price, Quote, News & History - Benzinga
What sentiment indicators say about Cingulate Inc. Equity Warrant stockTrade Signal Summary & Free Real-Time Volume Trigger Notifications - bolumsonucanavari.com
Will Cingulate Inc. Equity Warrant stock maintain dividend yieldMarket Trend Summary & High Conviction Buy Zone Picks - Улправда
Will Cingulate Inc. Equity Warrant stock benefit from upcoming earnings reportsTrade Ideas & Expert Approved Momentum Ideas - Улправда
Aug Breakouts: Will Cingulate Inc. stock return to pre crisis levels2025 Historical Comparison & Fast Moving Trade Plans - Улправда
How Cingulate Inc. stock performs in weak economyInsider Selling & High Accuracy Investment Signals - Улправда
Will Cingulate Inc. stock gain from lower inflationJuly 2025 Spike Watch & Reliable Breakout Forecasts - Улправда
Cingulate restores founder as CEO following concluded domestic battery case - The Business Journals
Cingulate Inc Reinstates Shane Schaffer as CEO - The Globe and Mail
Shane Schaffer reinstated as CEO of Cingulate - marketscreener.com
Cingulate reinstates Shane Schaffer as CEO, updates employment terms By Investing.com - Investing.com Canada
Cingulate reinstates Shane Schaffer as CEO, updates employment terms - Investing.com
Cingulate Inc. Announces Chief Executive Officer Changes, Effective December 15, 2025 - marketscreener.com
Cingulate presents Phase 3 results for CTx-1301, met primary endpoint - MSN
Ascendiant Capital Maintains Cingulate (CING) Buy Recommendation - Nasdaq
Cingulate reports Q3 net loss ($7.3M) vs ($4.1M) last year - MSN
Cingulate Inc (CING) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.90%
자본화:
|
볼륨(24시간):